NASDAQ:EXOZ
Exozymes Inc.
Exozymes Inc. reported net income of −$9.2M in fiscal 2025. Free cash flow was −$6.7M, and the diluted share count rose 27.7%.Summary generated from Exozymes Inc.'s SEC filings. Latest annual report filed Mar 30, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−132.6%
Debt / equityn/a
Free cash flow−$6.7M
FCF marginn/a
Share count change+27.7%
Financials
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 0 | n/a | n/a |
| Operating income | −2 | −6 | −10 |
| Net income | −2 | −6 | −9 |
| Free cash flow | −1 | −9 | −7 |
Recent filings
- 8-KOther events
Oct 9, 2026 - DEF 14AProxy statement
Sep 28, 2026 - 8-KOther events
Sep 18, 2026 - 4Insider transaction report
Sep 17, 2026 - 4Insider transaction report
Sep 2, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 13, 2026 - 8-KEntry into a material agreement
Jul 1, 2026 - 8-KRegulation FD disclosure
Jun 26, 2026